ELDRED KARY
SEC Form 4 insider trading activity
ELDRED KARY has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 9, 2026.
On the most recent filing, ELDRED KARY is listed as Director at GALECTIN THERAPEUTICS INC. Inside the rolling window, ELDRED KARY reported 2 open-market purchases totaling $3K in GALT and no open-market sales. The largest disclosed transaction in the window is a purchase of 700 GALT shares on Dec 23, 2025, worth $3K.
Companies traded
Other insiders at GALT
Insider Buying
$3K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ELDRED KARY made?
ELDRED KARY has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does ELDRED KARY trade?
ELDRED KARY has filed SEC Form 4 disclosures for 1 company, including GALT.
When was ELDRED KARY's most recent SEC Form 4 filing?
ELDRED KARY's most recent SEC Form 4 filing on Tracefour is dated Feb 9, 2026.
What is ELDRED KARY's total buy and sell value in the current window?
Inside the rolling retention window, ELDRED KARY bought $3K and sold $0 based on SEC Form 4 filings.
What was ELDRED KARY's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 700 GALT shares on 2025-12-23, worth $3K, per SEC Form 4 filings.